{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:43:54Z","timestamp":1787586234742,"version":"build-2736575974"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>Organ transplantation requires the use of immunosuppressive medications that lack antigen specificity, have many adverse side effects, and fail to induce immunological tolerance to the graft. The safe induction of tolerance to allogeneic tissue without compromising host responses to infection or enhancing the risk of malignant disease is a major goal in transplantation. One promising approach to achieve this goal is based on the concept of \u201cnegative vaccination.\u201d Vaccination (or actively acquired immunity) involves the presentation of both a foreign antigen and immunostimulatory adjuvant to the immune system to induce antigen-specific immunity. By contrast, negative vaccination, in the context of transplantation, involves the delivery of donor antigen before or after transplantation, together with a \u201cnegative adjuvant\u201d to selectively inhibit the alloimmune response. This review will explore established and emerging negative vaccination strategies for promotion of organ or pancreatic islet transplant tolerance. These include donor regulatory myeloid cell infusion, which has progressed to early-phase clinical trials, apoptotic donor cell infusion that has advanced to nonhuman primate models, and novel nanoparticle antigen-delivery systems.<\/jats:p>","DOI":"10.1097\/tp.0000000000004911","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T05:01:50Z","timestamp":1708059710000},"page":"1715-1729","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Negative Vaccination Strategies for Promotion of Transplant Tolerance"],"prefix":"10.1097","volume":"108","author":[{"given":"Matthew J.","family":"Tunbridge","sequence":"first","affiliation":[{"name":"Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia."},{"name":"Department of Medicine (Nephrology), Duke University Medical Center, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunrong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Medicine (Nephrology), Duke University Medical Center, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA."},{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.102.2651.400","article-title":"Immunogenetic consequences of vascular anastomoses between bovine twins.","volume":"102","author":"Owen","year":"1945","journal-title":"Science"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/172603a0","article-title":"Actively acquired tolerance of foreign cells.","volume":"172","author":"Billingham","year":"1953","journal-title":"Nature"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMe2204651","article-title":"Transplantation tolerance through hematopoietic chimerism.","volume":"386","author":"Spitzer","year":"2022","journal-title":"N Engl J Med"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/ijms24021752","article-title":"Treg therapy for the induction of immune tolerance in transplantation\u2014not lost in translation?","volume":"24","author":"Pilat","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrneph.2013.172","article-title":"Transplantation: negative vaccination to modulate transplant immunity.","volume":"9","author":"Azimzadeh","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MOT.0b013e328306116c","article-title":"Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.","volume":"13","author":"Turnquist","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution.","volume":"137","author":"Steinman","year":"1973","journal-title":"J Exp Med"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fimmu.2017.01514","article-title":"Update on dendritic cell-induced immunological and clinical tolerance.","volume":"8","author":"Obregon","year":"2017","journal-title":"Front Immunol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"643240","DOI":"10.3389\/fimmu.2021.643240","article-title":"Tolerogenic immunotherapy: targeting DC surface receptors to induce antigen-specific tolerance.","volume":"12","author":"Castenmiller","year":"2021","journal-title":"Front Immunol"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ni1522","article-title":"Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo.","volume":"8","author":"Naik","year":"2007","journal-title":"Nat Immunol"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.immuni.2007.06.006","article-title":"Development of dendritic-cell lineages.","volume":"26","author":"Wu","year":"2007","journal-title":"Immunity"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.12229","article-title":"Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance?","volume":"13","author":"Rogers","year":"2013","journal-title":"Am J Transplant"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/icb.2010.17","article-title":"Revisiting the tolerogenicity of epidermal Langerhans cells.","volume":"88","author":"Lutz","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/21645515.2015.1066050","article-title":"Duality at the gate: skin dendritic cells as mediators of vaccine immunity and tolerance.","volume":"12","author":"Nirschl","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOT.0b013e328355a979","article-title":"Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation.","volume":"17","author":"Broichhausen","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20082394","article-title":"Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity.","volume":"206","author":"Ohnmacht","year":"2009","journal-title":"J Exp Med"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.trre.2019.05.001","article-title":"Regulatory dendritic cells for human organ transplantation.","volume":"33","author":"Thomson","year":"2019","journal-title":"Transplant Rev (Orlando)"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.3390\/ijms22157970","article-title":"Regulatory macrophages and tolerogenic dendritic cells in myeloid regulatory cell-based therapies.","volume":"22","author":"Suuring","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.4049\/jimmunol.0903446","article-title":"Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-\/loFoxp3- effector T cells.","volume":"185","author":"Huang","year":"2010","journal-title":"J Immunol"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2012.168","article-title":"IFN-\u03b3-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients.","volume":"21","author":"Riquelme","year":"2013","journal-title":"Mol Ther"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MOT.0000000000000560","article-title":"Novel molecules mediate specialized functions of human regulatory macrophages.","volume":"23","author":"Riquelme","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/TP.0b013e3182a860de","article-title":"Regulatory myeloid cells in transplantation.","volume":"97","author":"Rosborough","year":"2014","journal-title":"Transplantation"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcyt.2022.11.005","article-title":"Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients.","volume":"25","author":"Zahorchak","year":"2023","journal-title":"Cytotherapy"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.kint.2022.08.037","article-title":"A phase I\/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.","volume":"103","author":"Moreau","year":"2023","journal-title":"Kidney Int"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellimm.2017.08.008","article-title":"High PD-L1\/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.","volume":"323","author":"Zahorchak","year":"2018","journal-title":"Cell Immunol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/tri.12988","article-title":"MITAP-compliant characterization of human regulatory macrophages.","volume":"30","author":"Hutchinson","year":"2017","journal-title":"Transpl Int"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.4049\/jimmunol.1100762","article-title":"Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.","volume":"187","author":"Hutchinson","year":"2011","journal-title":"J Immunol"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials.","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/ajt.16393","article-title":"Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients.","volume":"21","author":"Macedo","year":"2021","journal-title":"Am J Transplant"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood-2009-10-251058","article-title":"Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation.","volume":"116","author":"Divito","year":"2010","journal-title":"Blood"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOT.0000000000000097","article-title":"Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells.","volume":"19","author":"Morelli","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/TP.0000000000000871","article-title":"Eomesodermin(lo) CTLA4(hi) alloreactive CD8+ memory T cells are associated with prolonged renal transplant survival induced by regulatory dendritic cell infusion in CTLA4 immunoglobulin-treated nonhuman primates.","volume":"100","author":"Ezzelarab","year":"2016","journal-title":"Transplantation"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fimmu.2018.00250","article-title":"Donor-derived regulatory dendritic cell infusion maintains donor-reactive CD4(+)CTLA4(hi) T cells in non-human primate renal allograft recipients treated with CD28 co-stimulation blockade.","volume":"9","author":"Ezzelarab","year":"2018","journal-title":"Front Immunol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/ajt.14182","article-title":"Renal allograft survival in nonhuman primates infused with donor antigen-pulsed autologous regulatory dendritic cells.","volume":"17","author":"Ezzelarab","year":"2017","journal-title":"Am J Transplant"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/ajt.12310","article-title":"Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.","volume":"13","author":"Ezzelarab","year":"2013","journal-title":"Am J Transplant"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"eadf4287","DOI":"10.1126\/scitranslmed.adf4287","article-title":"Donor-derived regulatory dendritic cell infusion modulates CD8+ and NK cell responses after live donor liver transplantation.","volume":"15","author":"Tran","year":"2023","journal-title":"Sci Transl Med"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.TP.0000158277.50073.35","article-title":"Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression.","volume":"79","author":"B\u00e9riou","year":"2005","journal-title":"Transplantation"},{"key":"R38-20250604","first-page":"1366","article-title":"Granulocyte\/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival.","volume":"60","author":"Rastellini","year":"1995","journal-title":"Transplantation"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/ajt.12708","article-title":"Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation.","volume":"14","author":"Segovia","year":"2014","journal-title":"Am J Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1600-6143.2004.00673.x","article-title":"Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival.","volume":"5","author":"Taner","year":"2005","journal-title":"Am J Transplant"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00007890-199609150-00021","article-title":"Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.","volume":"62","author":"Fu","year":"1996","journal-title":"Transplantation"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8","article-title":"Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo.","volume":"30","author":"Lutz","year":"2000","journal-title":"Eur J Immunol"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.stemcr.2017.03.020","article-title":"iPSC-derived regulatory dendritic cells inhibit allograft rejection by generating alloantigen-specific regulatory T cells.","volume":"8","author":"Cai","year":"2017","journal-title":"Stem Cell Rep"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance.","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/tri.13504","article-title":"Tolerogenic dendritic cells in organ transplantation.","volume":"33","author":"Ochando","year":"2020","journal-title":"Transpl Int"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.","volume":"178","author":"Turnquist","year":"2007","journal-title":"J Immunol"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/intimm\/dxm142","article-title":"Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.","volume":"20","author":"Li","year":"2008","journal-title":"Int Immunol"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-6143.2004.00683.x","article-title":"Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors.","volume":"5","author":"P\u00eache","year":"2005","journal-title":"Am J Transplant"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bbrc.2010.04.062","article-title":"Uptake of donor lymphocytes treated with 8-methoxypsoralen and ultraviolet A light by recipient dendritic cells induces CD4+CD25+Foxp3+ regulatory T cells and down-regulates cardiac allograft rejection.","volume":"395","author":"Zheng","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1432-2277.2008.00692.x","article-title":"A cell-based approach to the minimization of immunosuppression in renal transplantation.","volume":"21","author":"Hutchinson","year":"2008","journal-title":"Transpl Int"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1432-2277.2008.00680.x","article-title":"Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation.","volume":"21","author":"Hutchinson","year":"2008","journal-title":"Transpl Int"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/37022","article-title":"Immunosuppressive effects of apoptotic cells.","volume":"390","author":"Voll","year":"1997","journal-title":"Nature"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1600-6143.2006.01308.x","article-title":"Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells.","volume":"6","author":"Wang","year":"2006","journal-title":"Am J Transplant"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2017.00909","article-title":"Anti-inflammatory mechanisms triggered by apoptotic cells during their clearance.","volume":"8","author":"Szondy","year":"2017","journal-title":"Front Immunol"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/ajt.13237","article-title":"Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells.","volume":"15","author":"McCarthy","year":"2015","journal-title":"Am J Transplant"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.1004175","article-title":"Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.","volume":"187","author":"Getts","year":"2011","journal-title":"J Immunol"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/ajt.15087","article-title":"Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance.","volume":"19","author":"Zhang","year":"2019","journal-title":"Am J Transplant"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4049\/jimmunol.1103705","article-title":"Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance.","volume":"189","author":"Kheradmand","year":"2012","journal-title":"J Immunol"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1096\/fba.2019-00029","article-title":"ECDI-fixed donor splenocytes prolong skin allograft survival by promoting M2 macrophage polarization and inducing regulatory T cells.","volume":"1","author":"Zhou","year":"2019","journal-title":"FASEB Bioadv"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/tri.12903","article-title":"Ethylene carbodiimide-fixed donor splenocytes combined with \u03b1-1 antitrypsin induce indefinite donor-specific protection to mice cardiac allografts.","volume":"30","author":"Lai","year":"2017","journal-title":"Transpl Int"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jss.2017.06.005","article-title":"Transfusion of ethylene carbodiimide-fixed donor splenocytes prolongs survival of vascularized skin allografts.","volume":"221","author":"Ding","year":"2018","journal-title":"J Surg Res"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1016\/j.biomaterials.2011.03.009","article-title":"Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions.","volume":"32","author":"Kheradmand","year":"2011","journal-title":"Biomaterials"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1521-6616(03)00141-4","article-title":"Alloantigen presentation by ethylcarbodiimide-treated dendritic cells induces T cell hyporesponsiveness, and prolongs organ graft survival.","volume":"108","author":"Kaneko","year":"2003","journal-title":"Clin Immunol"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"14527","DOI":"10.1073\/pnas.0805204105","article-title":"ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms.","volume":"105","author":"Luo","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.1000802","article-title":"Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.","volume":"185","author":"Martin","year":"2010","journal-title":"J Immunol"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.clim.2008.07.027","article-title":"Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.","volume":"129","author":"Albert","year":"2008","journal-title":"Clin Immunol"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1038\/s41467-019-11338-y","article-title":"Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes.","volume":"10","author":"Singh","year":"2019","journal-title":"Nat Commun"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1111\/j.1600-6143.2012.04203.x","article-title":"Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions.","volume":"12","author":"Chen","year":"2012","journal-title":"Am J Transplant"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.1302771","article-title":"Preemptive donor apoptotic cell infusions induce IFN-\u03b3-producing myeloid-derived suppressor cells for cardiac allograft protection.","volume":"192","author":"Bryant","year":"2014","journal-title":"J Immunol"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"919674","DOI":"10.3389\/fimmu.2022.919674","article-title":"TGF-\u03b2 enhances immunosuppression of myeloid-derived suppressor cells to induce transplant immune tolerance through affecting Arg-1 expression.","volume":"13","author":"Cao","year":"2022","journal-title":"Front Immunol"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"101405","DOI":"10.1016\/j.trim.2021.101405","article-title":"Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.","volume":"67","author":"Fujimoto","year":"2021","journal-title":"Transpl Immunol"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/eji.200939782","article-title":"Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg.","volume":"40","author":"Kushwah","year":"2010","journal-title":"Eur J Immunol"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/jo01351a600","article-title":"Notes- A convenient synthesis of water-soluble carbodiimides.","volume":"26","author":"Sheehan","year":"1961","journal-title":"J Org Chem"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1084\/jem.149.3.758","article-title":"The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.","volume":"149","author":"Miller","year":"1979","journal-title":"J Exp Med"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1084\/jem.165.2.302","article-title":"Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.","volume":"165","author":"Jenkins","year":"1987","journal-title":"J Exp Med"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/332161a0","article-title":"Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes.","volume":"332","author":"Madsen","year":"1988","journal-title":"Nature"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3727\/096368914X681027","article-title":"Preemptive tolerogenic delivery of donor antigens for permanent allogeneic islet graft protection.","volume":"24","author":"Wang","year":"2015","journal-title":"Cell Transplant"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"84","DOI":"10.21037\/atm.2019.12.146","article-title":"Blockade of OX40\/OX40L pathway combined with ethylene-carbodiimide-fixed donor splenocytes induces donor-specific allograft tolerance in presensitized recipients.","volume":"8","author":"Lai","year":"2020","journal-title":"Ann Transl Med"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.2337\/db12-1678","article-title":"Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts.","volume":"62","author":"Wang","year":"2013","journal-title":"Diabetes"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1038\/s41598-022-11290-w","article-title":"Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models.","volume":"12","author":"Schneiderman","year":"2022","journal-title":"Sci Rep"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ajt.16197","article-title":"Acute murine cytomegalovirus disrupts established transplantation tolerance and causes recipient allo-sensitization.","volume":"21","author":"Yu","year":"2021","journal-title":"Am J Transplant"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"e163872","DOI":"10.1172\/JCI163872","article-title":"Conversion of CD73hiFR4hi anergic T cells to IFN-\u03b3-producing effector cells disrupts established immune tolerance.","volume":"133","author":"Dangi","year":"2023","journal-title":"J Clin Invest"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1111\/j.1600-6143.2006.01489.x","article-title":"TLR engagement prevents transplantation tolerance.","volume":"6","author":"Chen","year":"2006","journal-title":"Am J Transplant"},{"key":"R84-20250604","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/ki.2015.262","article-title":"Cell-based immunosuppression in kidney transplantation: the value of non-human primate studies.","volume":"88","author":"Ezzelarab","year":"2015","journal-title":"Kidney Int"},{"key":"R85-20250604","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1615\/CritRevImmunol.v19.i5-6.10","article-title":"Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories.","volume":"19","author":"Kirk","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"R86-20250604","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1111\/ajt.13329","article-title":"Pilot study evaluating regulatory T cell-promoting immunosuppression and nonimmunogenic donor antigen delivery in a nonhuman primate islet allotransplantation model.","volume":"15","author":"Lei","year":"2015","journal-title":"Am J Transplant"},{"key":"R87-20250604","doi-asserted-by":"crossref","first-page":"101196","DOI":"10.1016\/j.trim.2019.02.001","article-title":"Ethylene carbodiimide-fixed donor splenocytes combined with cordycepin induce long-term protection to mice cardiac allografts.","volume":"56","author":"Xingqiang","year":"2019","journal-title":"Transpl Immunol"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1111\/ajt.15878","article-title":"Donor apoptotic cell-based therapy for effective inhibition of donor-specific memory T and B cells to promote long-term allograft survival in allosensitized recipients.","volume":"20","author":"Dangi","year":"2020","journal-title":"Am J Transplant"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.intimp.2015.02.035","article-title":"ECDI-fixed allogeneic splenocytes combined with \u03b11-antitrypsin prolong survival of rat renal allografts.","volume":"26","author":"Chen","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbmt.2013.10.010","article-title":"Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I\/IIa clinical trial.","volume":"20","author":"Mevorach","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R91-20250604","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition.","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"8 Suppl","key":"R92-20250604","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/TP.0b013e3181a07b08","article-title":"Inhibitors of the mammalian target of rapamycin and transplant tolerance.","volume":"87","author":"Bestard","year":"2009","journal-title":"Transplantation"},{"key":"R93-20250604","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/eci.12.33","article-title":"Tolerance without toxicity? \u03b11-antitrypsin as a novel alternative to immunosuppression.","volume":"8","author":"Goldstein","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1600-6143.2007.01842.x","article-title":"Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells.","volume":"7","author":"Gao","year":"2007","journal-title":"Am J Transplant"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1600-6143.2006.01344.x","article-title":"Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model.","volume":"6","author":"P\u00eache","year":"2006","journal-title":"Am J Transplant"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"32971","DOI":"10.1038\/srep32971","article-title":"Combining exosomes derived from immature DCs with donor antigen-specific Treg cells induces tolerance in a rat liver allograft model.","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"R97-20250604","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biomaterials.2019.04.030","article-title":"Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model.","volume":"210","author":"Shah","year":"2019","journal-title":"Biomaterials"},{"key":"R98-20250604","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R99-20250604","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.xphs.2022.01.030","article-title":"Tuning surface charges of peptide nanofibers for induction of antigen-specific immune tolerance: an introductory study.","volume":"111","author":"Lau","year":"2022","journal-title":"J Pharm Sci"},{"key":"R100-20250604","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1021\/acsnano.8b01625","article-title":"Murine and non-human primate dendritic cell targeting nanoparticles for in vivo generation of regulatory T-cells.","volume":"12","author":"Stead","year":"2018","journal-title":"ACS Nano"},{"key":"R101-20250604","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biomaterials.2017.11.017","article-title":"Manipulating human dendritic cell phenotype and function with targeted porous silicon nanoparticles.","volume":"155","author":"Stead","year":"2018","journal-title":"Biomaterials"},{"key":"R102-20250604","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","article-title":"Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance.","volume":"49","author":"Braza","year":"2018","journal-title":"Immunity"},{"key":"R103-20250604","doi-asserted-by":"crossref","first-page":"eabe7853","DOI":"10.1126\/sciadv.abe7853","article-title":"A modular approach toward producing nanotherapeutics targeting the innate immune system.","volume":"7","author":"van Leent","year":"2021","journal-title":"Sci Adv"},{"key":"R104-20250604","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nri723","article-title":"C-type lectin receptors on dendritic cells and Langerhans cells.","volume":"2","author":"Figdor","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R105-20250604","first-page":"844","article-title":"Specialized role of migratory dendritic cells in peripheral tolerance induction.","volume":"123","author":"Idoyaga","year":"2013","journal-title":"J Clin Invest"},{"key":"R106-20250604","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.1102307","article-title":"Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity.","volume":"187","author":"Loschko","year":"2011","journal-title":"J Immunol"},{"key":"R107-20250604","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jaci.2018.07.030","article-title":"Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity.","volume":"142","author":"Mathiesen","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R108-20250604","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1016\/j.biomaterials.2014.06.044","article-title":"Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation.","volume":"35","author":"Bryant","year":"2014","journal-title":"Biomaterials"},{"key":"R109-20250604","doi-asserted-by":"crossref","first-page":"e2300670","DOI":"10.1002\/adhm.202300670","article-title":"Programmed death ligand-1-overexpressing donor exosomes mediate donor-specific immunosuppression by delivering co-inhibitory signals to donor-specific T cells.","volume":"12","author":"Luo","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"R110-20250604","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/01.TP.0000092494.75313.38","article-title":"Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.","volume":"76","author":"P\u00eache","year":"2003","journal-title":"Transplantation"},{"key":"R111-20250604","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/TP.0000000000004473","article-title":"Meeting report: the Fifth International Samuel Strober Workshop on Clinical Immune Tolerance.","volume":"107","author":"Sykes","year":"2023","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:04:01Z","timestamp":1749060241000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004911","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}